Bellevue Life Sciences Acquisition Corp. Uncategorized Contracts & Agreements
15 Contracts & Agreements
- Business Combination Agreement, dated as of November 16, 2023, between Bellevue Life Sciences Acquisition Corp. and OSR Holdings Co., Ltd (Filed With SEC on November 16, 2023)
- Description of Securities (Filed With SEC on March 31, 2023)
- Amended and Restated Administrative Support Agreement, dated February 9, 2023, by and between the Company and the Sponsor (Filed With SEC on February 15, 2023)
- Form of Amended and Restated Administrative Support Agreement by and between the Registrant and Bellevue Global Life Sciences Investors LLC (Filed With SEC on January 20, 2023)
- Amended and Restated Administrative Support Agreement, dated November 4, 2022 by and between the Registrant and Bellevue Global Life Sciences Investors LLC (Filed With SEC on November 4, 2022)
- Amended and Restated Administrative Support Agreement, dated , 2022 by and between the Registrant and Bellevue Global Life Sciences Investors LLC (Filed With SEC on October 7, 2022)
- Form of Letter Agreement among the Registrant and our officers, directors, Chardan Capital Markets, LLC and Bellevue Global Life Sciences Investors LLC (Filed With SEC on October 7, 2022)
- Specimen Rights Certificate (Filed With SEC on October 7, 2022)
- Specimen Unit Certificate (Filed With SEC on October 7, 2022)
- Administrative Support Agreement, dated April 20, 2022 by and between the Registrant and Bellevue Global Life Sciences Investors LLC (Filed With SEC on May 10, 2022)
- Form of Letter Agreement among the Registrant and our officers, directors, Chardan Capital Markets, LLC and Bellevue Global Life Sciences Investors LLC (Filed With SEC on May 10, 2022)
- Administrative Support Agreement, dated April 20, 2022 by and between the Registrant and Bellevue Global Life Sciences Investors LLC (Filed With SEC on April 29, 2022)
- Form of Indemnity Agreement (Filed With SEC on April 29, 2022)
- Form of Letter Agreement among the Registrant and our officers, directors, Chardan Capital Markets, LLC and Bellevue Global Life Sciences Investors LLC (Filed With SEC on April 29, 2022)
- Specimen Unit Certificate (Filed With SEC on April 29, 2022)